Premium
Serum lipid level in Iranian patients with psoriasis
Author(s) -
Farshchian M,
Zamanian A,
Farshchian M,
Monsef AR,
Mahjub H
Publication year - 2007
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.2006.02099.x
Subject(s) - psoriasis , medicine , triglyceride , lipid profile , outpatient clinic , gastroenterology , very low density lipoprotein , psoriasis area and severity index , body mass index , cholesterol , blood lipids , lipoprotein , dermatology
Background Psoriasis is a common, chronic, inflammatory and proliferative skin disease associated with abnormal lipid metabolism. Previous studies have demonstrated that patients with psoriasis may have an increased risk of occlusive vascular disease. Objectives The aim of this study was to determine lipid profile in Iranian patients with psoriasis. Subjects and methods A cross‐sectional study was performed in 30 patients with approved psoriasis diagnosis attending the Dermatology Outpatient Department at Sina Hospital, Hamedan, Iran and 30 matched healthy individuals. Fasting blood sugar (FBS), triglyceride, cholesterol, high‐density lipoprotein (HDL), low‐density lipoprotein (LDL) and very low‐density lipoprotein (VLDL) were measured using standard enzymatic method. The psoriasis activity was evaluated by psoriasis area and severity index (PASI Index). Results FBS levels were higher in patients with psoriasis diagnosis but the differences were not significant ( P ‐value = 0.284). There were no significant differences between serum levels of triglyceride and cholesterol in two groups. There were no differences in lipoproteins (HDL, LDL, VLDL) compared with control subjects. ( P ‐value > 0.05) PASI Index and lipid profile did not have any significant correlation. The correlation between duration of disease and LDL were significant ( P ‐value = 0.033). Conclusion Lipid profile in Iranian patients with psoriasis did not differ compared with control‐matched subjects.